Mavodelpar

DB17662InvestigationalSmall molecule

Mavodelpar: Overview.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor delta
Curator reviewed
Formula / weight: C₃₁H₃₀FNO₅ · 515.581 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyUAQOKKXVCNQHIP-IPPBACCNSA-NSMILESCC1=CC(OC\C=C(\C2=CC=C(F)C=C2)C2=CC=C(C=C2)C#CCN2CCOCC2)=CC=C1OCC(O)=O

Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mavodelpar, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.